Recombinant SARS-CoV-2 Spike S1 抗体 (RBD)
-
- 抗原 See all SARS-CoV-2 Spike S1 抗体
- SARS-CoV-2 Spike S1
- 抗体类型
- Recombinant Antibody
-
抗原表位
- RBD
-
适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
-
宿主
-
Human
-
克隆类型
- 单克隆
-
标记
- This SARS-CoV-2 Spike S1 antibody is un-conjugated
-
应用范围
- ELISA, Immunofluorescence (IF), Crystallization (Crys), Surface Plasmon Resonance (SPR)
- 原理
- Recombinant monoclonal antibody to COVID-19 & SARS-CoV S glycoprotein.
- 特异性
-
The antibody CR3022 binds the amino acids 318-510 in the S1 domain of the SARS-CoV Spike protein as well as SARS-CoV-2 (COVID-19) Spike protein. The antibody also binds to P462L-substituted S318-510 fragments of the SARS spike protein. The binding epitope is only accessible in the "open" conformation of the spike protein (Joyce et al. 2020).
While most S-protein RBD binding antibodies compete for antigen binding with ACE2, the CR3022 epitope does not overlap with the ACE2-binding site. It does thus not hinder binding of neutralizing antibodies. While CR3022 on its own exhibits only a weak neutralizing effect, it has been shown to synergize with other S-protein RBD binding antibodies to neutralize SARS-CoV. This effect still has to be confirmed in context with SARS-CoV-2 (Yuan et al. 2020).
- 交叉反应 （详细）
- The anti-SARS-CoV-2 antibody CR3022 was originally discovered in a SARS patient, but it was shown to be a potent binder of SARS-CoV-2 spike protein (S1).
- 产品特性
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- 纯化方法
- Affinity Purified using a recombinant lectin column
- 免疫原
- The original monoclonal antibody was generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV.
- 克隆位点
- CR3022
- 亚型
- IgM kappa
- Top Product
- Discover our top product SARS-CoV-2 Spike S1 Primary Antibody
-
anti-SARS-CoV-2 Spike S1 (RBD) antibody
适用: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV), SARS CoV-2 Alpha, SARS CoV-2 Epsilon, SARS CoV-2 Gamma, SARS CoV-2 Beta, SARS CoV-2 Eta, SARS CoV-2 Kappa, SARS CoV-2 Omicron, SARS CoV-2 Delta ELISA, IF, Crys, SPR, mIHC 宿主: Human Monoclonal CR3022 unconjugated Recombinant Antibody
anti-SARS-CoV-2 Spike S1 (RBD) antibody适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, Neut 宿主: Human Monoclonal unconjugated Recombinant Antibody
anti-SARS-CoV-2 Spike S1 (RBD) antibody适用: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV), SARS CoV-2 Alpha, SARS CoV-2 Epsilon, SARS CoV-2 Gamma, SARS CoV-2 Beta, SARS CoV-2 Eta, SARS CoV-2 Kappa ELISA, IF, Crys, SPR 宿主: 兔 Chimeric CR3022 unconjugated Recombinant Antibody
anti-SARS-CoV-2 Spike S1 (RBD) antibody适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, Neut, GICA 宿主: Human Monoclonal A1 unconjugated single-domain Antibody (sdAb) Recombinant Antibody
anti-SARS-CoV-2 Spike S1 antibody适用: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Alpha, SARS CoV-2 Epsilon, SARS CoV-2 Gamma, SARS CoV-2 Beta ELISA, Neut 宿主: Human Chimeric AM122 unconjugated
anti-SARS-CoV-2 Spike S1 antibody适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, GICA 宿主: Human Chimeric H6 unconjugated Recombinant Antibody
anti-SARS-CoV-2 Spike S1 (RBD) antibody适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA 宿主: 兔 Polyclonal unconjugated
anti-SARS-CoV-2 Spike S1 antibody (Biotin)适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA 宿主: Human Monoclonal H6 Biotin scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Spike S1 antibody (HRP)适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA 宿主: Human Monoclonal H6 HRP scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Spike S1 antibody适用: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Alpha ELISA, IHC 宿主: 兔 Monoclonal SP185 unconjugated
-
- 应用备注
- This antibody (CR3022) binds to both SARS-CoV and SARS-CoV-2 with high affinity. The initial characterization of the binding of this antibody was performed by ELISA and indicates potential for the development of diagnostic assays, as both virus-capture assays, or as controls in serological assays measuring immune-responses to virus exposure. Human IgG1, IgG3, IgM and IgA isotypes are available to mimic antibody responses seen in COVID19 (Amanat et al. 2020). Human IgG2 is available to assess its yet unknown role in the response to SARS-CoV-2. The original human IgG1 version of the antibody works synergistically in combination with another non-competing SARS antibody CR3014 and is a potential candidate for passive immune prophylaxis of SARS-CoV infection (Meulen et al., 2006). The original antibody (human IgG1) was also reported to bind the 2019-nCoV RBD (KD of 6.3 nM). This antibody has been attributed a potential to be developed as a therapeutic agent, alone or in combination with other neutralizing antibodies for treatment of 2019-nCoV infections (Tian et al., 2020).
- 说明
-
This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- PBS with 0.02 % Proclin 300.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- 抗原
- SARS-CoV-2 Spike S1
- Abstract
- SARS-CoV-2 Spike S1 产品
- 别名
- E2 antibody, Surface Glycoprotein antibody, S antibody
- 物质类
- Viral Protein
- 背景
- Spike protein, COVID19, COVID 19, S protein, SARS-CoV S protein, S glycoprotein, E2, Peplomer protein, Spike protein S1, SARS Coronavirus, SARS-CoV-2, SARS CoV 2, 2019-nCoV
- UniProt
- P59594
-
